1638851-44-1
1638851-44-1
Chemical Structure
HSK0935
- CAS No.: 1638851-44-1
- Formula:C22H25ClO7
- Molecular Weight:436.88
IUPAC Name: (1S,2S,3R,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-methoxy-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
InChIKey: UFWQAQJFRMQRFR-CUUWFGFTSA-N
SMILES: ClC(C=C1)=C(CC2=CC=C(OCC)C=C2)C=C1[C@@]3(OC4)[C@H](O)[C@@H](O)[C@H](O)[C@@]4(OC)O3
Biological Activity: HSK0935 is a potent, highly selective and orally available SGLT2 inhibitor with an IC50 of 1.3 nM. Antihyperglycemic activities[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HSK0935 | 96.39% | HSK0935 is a potent, highly selective and orally available SGLT2 inhibitor with an IC50 of 1.3 nM. Antihyperglycemic activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HSK0935 (Standard) | ≥98% | HSK0935 (Standard) is the analytical standard of HSK0935 (HY-101782). This product is intended for research and analytical applications. HSK0935 is a potent, highly selective and orally available SGLT2 inhibitor with an IC50 of 1.3 nM. Antihyperglycemic activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
